NCT06986174
- Conditions
- B-Cell Lymphoproliferative Disorder, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Indolent Lymphoma
Explore clinical trials studying Indolent Lymphoma. Study availability and eligibility vary by location and protocol.
9 public trials
1 recruiting study
Indolent Lymphoma trial results
Not Yet Recruiting
Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma
NCT07609446
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Not Yet Recruiting
Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Indolent Lymphoma
NCT07459608
- Conditions
- CLL / SLL, Indolent Lymphoma, MZL, +1 more
- Locations
-
- Henan cancer hospital Zhengzhou, Henan, China
Not Yet Recruiting
Pomalidomide Combined With Obinutuzumab in the Treatment of Patients With Relapsed/Refractory Indolent Lymphoma
NCT07441954
- Conditions
- Indolent Lymphoma
- Locations
-
Not specified
NCT03133221
- Conditions
- B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +34 more
- Locations
-
- University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
- Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT03424603
- Conditions
- B Cells--Tumors, B-cell Lymphoma, Blood Protein Disorders, +26 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Arizona Oncology Associates, PC--HOPE Division Tucson, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- UC Davis Comprehensive Cancer Center Sacramento, California, United States
NCT00980395
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
NCT01263899
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +11 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Weill Medical College of Cornell New York, United States
- University of Rochester James P. Wilmot Cancer Center Rochester, New York, United States
- MD Anderson Cancer Canter Houston, Texas, United States
Active, Not Recruiting
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
NCT05020678
- Conditions
- Aggressive Lymphoma, B-cell Acute Lymphoblastic Leukemia, Blood Protein Disorders, +43 more
- Locations
-
- Colorado Blood Cancer Institute Denver, Colorado, United States
- The Cleveland Clinic Foundation Cleveland, Ohio, United States
- Institute of Haematology, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- St. Vincent's Hospital Sydney, New South Wales, Australia